Merck CEO Robert Davis discusses FDA approval of its pulmonary arterial hypertension drug

'Mad Money' host Jim Cramer speaks with Robert Davis, chairman and CEO of Merck, after the FDA approved the pharmaceutical company's pulmonary arterial hypertension drug, Winrevair.